Harvard Bioscience Inc (HBIO) insider trading

Every open-market stock purchase and sale by Harvard Bioscience Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $202K over the last 12 months (4 buys).
  • Last insider buy: Stephen J Denelsky (Director), $48.7K, 7 months ago.

Last 12 months: insiders bought $202K (4 buys) and sold $0 (0 sales). Last close $6.20 on Jun 4, 2026.

Recent HBIO insider trades

DateInsiderTradeValue
Jun 9, 2026Katherine A. Eade (Director)Bought (not open market)—
Jun 9, 2026Seth Benjamin Benson (Director)Bought (not open market)—
Jun 9, 2026Stephen J Denelsky (Director)Bought (not open market)—
Jun 9, 2026William Snider (Director)Bought (not open market)—
Jun 9, 2026Robert E. Gagnon (Director)Bought (not open market)—
Mar 20, 2026John D Duke (CEO)Bought (not open market)—
Mar 20, 2026Mark T Frost (CFO)Bought (not open market)—
Mar 17, 2026Stephen J Denelsky (Director)Bought$48.7K
Mar 17, 2026William Snider (Director)Bought$41.1K
Mar 16, 2026William Snider (Director)Bought$62.5K
Mar 16, 2026John D Duke (CEO)Bought$25.1K
Mar 16, 2026Mark T Frost (CFO)Bought$25K
Dec 17, 2025William Snider (Director)Bought (not open market)—

Who's trading HBIO

Get free alerts when an insider at Harvard Bioscience Inc files a new trade →